Press Releases
Search
-
15 Dec 2004
bioMérieux acquires an option to license Applied NeuroSolutions’ Technology to diagnose Alzheimer’s disease
Marcy L’Etoile, France - December 15th, 2004. bioMérieux SA (Euronext: FR0010096479 – BIM) , announces today that it signed a non-exclusive agreement with Applied Neurosolutions granting bioMérieux SA...
-
05 Nov 2004
bioMérieux reveals VIDIA, its new automated immunoanalyser, in Paris at the Journées Internationales de Biologie
Marcy l'Etoile, France - November 5th, 2004. A major player in the in vitro diagnostics marketplace, bioMérieux announces the first official presentation of its new fully automated immunoanalyser, VID...
-
25 Oct 2004
bioMérieux to assess potential of PlasmAcute® Technology for tuberculosis testing
Bergen, Norway - October 25, 2004. Novel Diagnostics ASA and bioMérieux announced today that they have signed an agreement that gives bioMérieux access to patented PlasmAcute® acute phase antibody det...
-
20 Oct 2004
Nine-Month Sales Up 5.6% at Constant Exchange Rates
Marcy l'Etoile, France - October 20th, 2004. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its sales for the first nine months of 2004.
-
07 Oct 2004
bioMérieux signs New Agreements with Gen-Probe
Marcy l'Etoile, France - October 7th, 2004. bioMérieux receives a $ 1 million license fee for access to its markers for blood clotting disorders. bioMérieux to give Gen-Probe an option for the access ...
-
01 Oct 2004
Appointment of an Independent Board Member - Composition of Audit and Compensation Committees
Marcy l'Etoile, France - October 1st, 2004. bioMérieux announces the nomination of a new independent Board Member, Mr Michel Angé, Vice-Président of APICIL-Prévoyance, to its Board of Directors. This ...